Exact Mass: 497.19843160000005

Exact Mass Matches: 497.19843160000005

Found 500 metabolites which its exact mass value is equals to given mass value 497.19843160000005, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Validamycin A

2-(hydroxymethyl)-6-[(2,3,5-trihydroxy-6-methyl-4-{[4,5,6-trihydroxy-3-(hydroxymethyl)cyclohex-2-en-1-yl]amino}cyclohexyl)oxy]oxane-3,4,5-triol

C20H35NO13 (497.21083000000004)

Validamycin A is used in control of fungal infection in rice, potatoes, strawberries and other crops. It is used in control of fungal infection in rice, potatoes, strawberries and other crops Validamycin A, a fungicidal, is an agricultural antibiotic. Validamycin A is originally isolated from Streptomyces hygroscopicus var. limoneus. Validamycin A inhibits the growth of A. flavus, with a MIC of 1?μg/mL[1]. Validamycin A shows potent inhibitory activity against trehalase of Rhizoctonia solani, with an IC50 of 72 μM[2]. Validamycin A is a reversible tyrosinase inhibitor, with a Ki of 5.893 mM[3].

Mafoprazine mesylate

C23H32FN3O6S (497.1995744)

Idarubicin

(7S,9S)-9-acetyl-7-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,9,11-trihydroxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione

C26H27NO9 (497.1685732000001)

Idarubicin is only found in individuals that have used or taken this drug. It is an orally administered anthracycline antineoplastic. The compound has shown activity against breast cancer, lymphomas and leukemias, together with the potential for reduced cardiac toxicity. [PubChem]Idarubicin has antimitotic and cytotoxic activity through a number of proposed mechanisms of action: Idarubicin forms complexes with DNA by intercalation between base pairs, and it inhibits topoisomerase II activity by stabilizing the DNA-topoisomerase II complex, preventing the religation portion of the ligation-religation reaction that topoisomerase II catalyzes. L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors

Dexamethasone isonicotinate

[2-(9-Fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl)-2-oxoethyl] pyridine-4-carboxylate

C28H32FNO6 (497.2213544)

(9S)-9-Acetyl-7-[(2R,4S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-8,10-dihydro-7H-tetracene-5,12-dione

C26H27NO9 (497.1685732000001)

D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors D004791 - Enzyme Inhibitors

N-[[3-[(2S)-2-Hydroxy-3-[[2-[4-[(phenylsulfonyl)amino]phenyl]ethyl]amino]propoxy]phenyl]methyl]-acetamide

N-[[3-[(2S)-2-Hydroxy-3-[[2-[4-[(phenylsulphonyl)amino]phenyl]ethyl]amino]propoxy]phenyl]methyl]-acetamide

C26H31N3O5S (497.19843160000005)

6-benzoyloxy-2-(hydroxy-phenyl-methyl)-8-methyl-3-(3-phenyl-acryloyloxy)-nortropane

C31H31NO5 (497.2202116)

(R)-(1E)-5-methoxy-6-hydroxy-cinnamyl-(1->6)-dihydrochelerythrine|zanthocapensine

C30H27NO6 (497.18382820000005)

Daunomycin|Daunomycin-11-deoxy,13-deoxo; B,HCl

C27H31NO8 (497.2049566)

C27H31NO8

C27H31NO8 (497.2049566)

11-deoxy-13-deoxodaunorubicin

C27H31NO8 (497.2049566)

1,5-Lactan,2,3-di-N-benzyloxycarbonyl,4-tetrahydropyranyl-(2S,3S,4R)-2,3,5-Triamino-4-hydroxypentanoic acid

C26H31N3O7 (497.2161896)

His Asn Val Glu

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]-3-methylbutanamido]pentanedioic acid

C20H31N7O8 (497.2234006)

His Asn Ile Asp

(2S)-2-[(2S,3S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]-3-methylpentanamido]butanedioic acid

C20H31N7O8 (497.2234006)

His Ala Gly Asp Val

C20H31N7O8 (497.2234006)

Ala His Gly Val Asp

C20H31N7O8 (497.2234006)

Idarubicin

C26H27NO9 (497.1685732000001)

L - Antineoplastic and immunomodulating agents > L01 - Antineoplastic agents > L01D - Cytotoxic antibiotics and related substances > L01DB - Anthracyclines and related substances C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C259 - Antineoplastic Antibiotic C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors

Ala Phe Phe Asn

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-phenylpropanamido]-3-carbamoylpropanoic acid

C25H31N5O6 (497.2274226)

Ala Phe Asn Phe

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-3-phenylpropanamido]-3-carbamoylpropanamido]-3-phenylpropanoic acid

C25H31N5O6 (497.2274226)

Ala Met Asn Tyr

(2S)-2-[(2S)-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-(methylsulfanyl)butanamido]-3-carbamoylpropanamido]-3-(4-hydroxyphenyl)propanoic acid